loadpatents
Patent applications and USPTO patent grants for Lim; Jongwon.The latest application filed is for "novel arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors".
Patent | Date |
---|---|
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,319,283 - McGowan , et al. May 3, 2 | 2022-05-03 |
Novel Arylalkyl Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210380572 - Clausen; Dane ;   et al. | 2021-12-09 |
Novel Aryloxypiperidine Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210330676 - Clausen; Dane ;   et al. | 2021-10-28 |
Prmt5 Inhibitors App 20210309688 - Lim; Jongwon ;   et al. | 2021-10-07 |
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 11,111,232 - White , et al. September 7, 2 | 2021-09-07 |
Cyclic Di-nucleotide Compounds As Sting Agonists App 20210206796 - Andresen; Brian M. ;   et al. | 2021-07-08 |
Sting agonist compounds Grant 10,793,557 - Altman , et al. October 6, 2 | 2020-10-06 |
Novel Substituted Cyclobutylpyridine And Cyclobutylpyrimidine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200290996 - White; Catherine M. ;   et al. | 2020-09-17 |
Cyclic di-nucleotide compounds as sting agonists Grant 10,766,919 - Altman , et al. Sep | 2020-09-08 |
Novel Substituted Cyclobutylbenzene Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200277252 - McGowan; Meredeth Ann ;   et al. | 2020-09-03 |
Compounds that are ERK inhibitors Grant 10,759,805 - Lim , et al. Sep | 2020-09-01 |
Cyclic di-nucleotide compounds as STING agonists Grant 10,759,825 - Altman , et al. Sep | 2020-09-01 |
Benzo[b]thiophene compounds as STING agonists Grant 10,730,849 - Altman , et al. | 2020-08-04 |
Benzo[b]thiophene compounds as STING agonists Grant 10,703,738 - Altman , et al. | 2020-07-07 |
Cyclic Di-nucleotide Compounds As Sting Agonists App 20200062798 - WU; Wen-Lian ;   et al. | 2020-02-27 |
Aryl Sulfonamides As Blt1 Antagonists App 20190382363 - Han; Yongxin ;   et al. | 2019-12-19 |
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS App 20190337918 - Altman; Michael D. ;   et al. | 2019-11-07 |
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS App 20190337917 - Altman; Michael D. ;   et al. | 2019-11-07 |
Sting Agonist Compounds App 20190300513 - Altman; Michael D. ;   et al. | 2019-10-03 |
Benzo[b]thiophene compounds as sting agonists Grant 10,414,747 - Altman , et al. Sept | 2019-09-17 |
Aryl acylsulfonamides as BLT1 antagonists Grant 10,336,733 - Han , et al. | 2019-07-02 |
Pyrazolopyrimidine inhibitors of IRAK4 activity Grant 10,329,294 - Lim , et al. | 2019-06-25 |
Pyrrolotriazine inhibitors of IRAK4 activity Grant 10,329,295 - Lim , et al. | 2019-06-25 |
Carboxamide inhibitors of IRAK4 activity Grant 10,155,765 - Lim , et al. Dec | 2018-12-18 |
Novel Compounds That Are Erk Inhibitors App 20180319804 - Lim; Jongwon ;   et al. | 2018-11-08 |
Aryl Acylsulfonamides As Blt1 Antagonists App 20180305342 - Han; Yongxin ;   et al. | 2018-10-25 |
Cyclic di-nucleotide compounds as sting agonists Grant 10,106,574 - Altman , et al. October 23, 2 | 2018-10-23 |
Compounds that are ERK inhibitors Grant 10,065,967 - Lim , et al. September 4, 2 | 2018-09-04 |
Cyclic Di-nucleotide Compounds As Sting Agonists App 20180244712 - Altman; Michael D. ;   et al. | 2018-08-30 |
Cyclic Di-nucleotide Compounds As Sting Agonists App 20180237469 - Altman; Michael D. ;   et al. | 2018-08-23 |
Thienopyrazine inhibitors of IRAK4 activity Grant 10,040,802 - Lim , et al. August 7, 2 | 2018-08-07 |
Pyrrolopyridazine inhibitors of IRAK4 activity Grant 10,040,798 - Lim , et al. August 7, 2 | 2018-08-07 |
Inhibitors of IRAK4 activity Grant 9,969,749 - Altman , et al. May 15, 2 | 2018-05-15 |
Inhibitors of IRAK4 activity Grant 9,943,516 - Altman , et al. April 17, 2 | 2018-04-17 |
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS App 20180093964 - Altman; Michael D. ;   et al. | 2018-04-05 |
Inhibitors of IRAK4 activity Grant 9,932,350 - Altman , et al. April 3, 2 | 2018-04-03 |
Inhibitors of IRAK4 activity Grant 9,926,330 - Altman , et al. March 27, 2 | 2018-03-27 |
Pyrrolopyridazine Inhibitors Of Irak4 Activity App 20180051029 - LIM; JONGWON ;   et al. | 2018-02-22 |
Pyrrolotriazine Inhibitors Of Irak4 Activity App 20180051030 - LIM; JONGWON ;   et al. | 2018-02-22 |
Pyrazolopyrimidine Inhibitors Of Irak4 Activity App 20180051028 - LIM; JONGWON ;   et al. | 2018-02-22 |
Thienopyrazine Inhibitors Of Irak4 Activity App 20180051035 - LIM; JONGWON ;   et al. | 2018-02-22 |
Carboxamide Inhibitors Of Irak4 Activity App 20180051027 - LIM; JONGWON ;   et al. | 2018-02-22 |
ERK inhibitors Grant 9,884,048 - Siliphaivanh , et al. February 6, 2 | 2018-02-06 |
Novel Compounds That Are Erk Inhibitors App 20170320882 - Lim; Jongwon ;   et al. | 2017-11-09 |
Inhibitors Of Irak4 Activity App 20170275297 - ALTMAN; MICHAEL D. ;   et al. | 2017-09-28 |
Erk Inhibitors App 20170266167 - Siliphaivanh; Phieng ;   et al. | 2017-09-21 |
Inhibitors Of Irak4 Activity App 20170247388 - ALTMAN; MICHAEL D. ;   et al. | 2017-08-31 |
Compounds that are ERK inhibitors Grant 9,745,307 - Lim , et al. August 29, 2 | 2017-08-29 |
Inhibitors Of Irak4 Activity App 20170217981 - ALTMAN; MICHAEL D. ;   et al. | 2017-08-03 |
Inhibitors Of Irak4 Activity App 20170209446 - ALTMAN; MICHAEL D. ;   et al. | 2017-07-27 |
Cyclic Di-nucleotide Compounds As Sting Agonists App 20170044206 - Altman; Michael D. ;   et al. | 2017-02-16 |
Imidazolyl analogs as syk inhibitors Grant 9,487,504 - Lim , et al. November 8, 2 | 2016-11-08 |
Substituted Amidopyrazole Inhibitors Of Interleukin Receptor-associated Kinases (irak-4) App 20160166576 - LIM; Jongwon ;   et al. | 2016-06-16 |
Novel Compounds That Are Erk Inhibitors App 20160068532 - Lim; Jongwon ;   et al. | 2016-03-10 |
Pyrazolyl derivatives as Syk inhibitors Grant 9,242,984 - Machacek , et al. January 26, 2 | 2016-01-26 |
Compounds that are ERK inhibitors Grant 9,233,979 - Wilson , et al. January 12, 2 | 2016-01-12 |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors Grant 9,221,809 - Seganish , et al. December 29, 2 | 2015-12-29 |
Novel Compounds That Are Erk Inhibitors App 20150266895 - Wilson; Kevin J. ;   et al. | 2015-09-24 |
Pyrazolyl Derivatives As Syk Inhibitors App 20150191461 - Machacek; Michelle R. ;   et al. | 2015-07-09 |
Imidazolyl Analogs As Syk Inhibitors App 20150175575 - Lim; Jongwon ;   et al. | 2015-06-25 |
Compounds that are ERK inhibitors Grant 9,023,865 - Lim , et al. May 5, 2 | 2015-05-05 |
Pyrazolo[1,5-A]pyrimidines as mark inhibitors Grant 8,946,237 - Lim , et al. February 3, 2 | 2015-02-03 |
Aminopyrimidinones As Interleukin Receptor-associated Kinase Inhibitors App 20140329799 - Seganish; W. Michael ;   et al. | 2014-11-06 |
Novel Compounds That Are Erk Inhibitors App 20140296203 - Lim; Jongwon ;   et al. | 2014-10-02 |
Aminopyrimidines as SYK Inhibitors App 20140243290 - Altman; Michael D. ;   et al. | 2014-08-28 |
Aminopyrimidines as Syk inhibitors Grant 8,735,417 - Altman , et al. May 27, 2 | 2014-05-27 |
Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors Grant 8,592,425 - Altman , et al. November 26, 2 | 2013-11-26 |
Aminopyrimidines as SYK inhibitors Grant 8,551,984 - Altman , et al. October 8, 2 | 2013-10-08 |
Pyrazolo[1,5-a]pyrimidines As Mark Inhibitors App 20130210838 - Lim; Jongwon ;   et al. | 2013-08-15 |
Pyrazolo[1,5-a]pyrimidine derivatives Grant 8,461,162 - Stanton , et al. June 11, 2 | 2013-06-11 |
Inhibitors of janus kinases Grant 8,431,569 - Young , et al. April 30, 2 | 2013-04-30 |
Inhibitors of janus kinases Grant 8,367,706 - Altman , et al. February 5, 2 | 2013-02-05 |
Aminopyrimidines As Syk Inhibitors App 20120309735 - Altman; Michael D. ;   et al. | 2012-12-06 |
Aminopyrimidines As Syk Inhibitors App 20120277192 - Altman; Michael D. ;   et al. | 2012-11-01 |
IMIDAZO[1,2-A]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS App 20120010209 - Altman; Michael D. ;   et al. | 2012-01-12 |
Aminopyrimidines As Syk Inhibitors App 20110245205 - Altman; Michael D. ;   et al. | 2011-10-06 |
PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES App 20100305091 - Stanton; Matthew G. ;   et al. | 2010-12-02 |
Inhibitors Of Janus Kinases App 20100267709 - Young; Jonathan R. ;   et al. | 2010-10-21 |
Inhibitors Of Janus Kinases App 20100256097 - Altman; Michael ;   et al. | 2010-10-07 |
Tyrosine kinase inhibitors Grant 7,790,739 - Lim , et al. September 7, 2 | 2010-09-07 |
Tyrosine Kinase Inhibitors App 20090291941 - Dinsmore; Christopher J. ;   et al. | 2009-11-26 |
Tyrosine Kinase Inhibitors App 20090247565 - Lim; Jongwon ;   et al. | 2009-10-01 |
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met App 20090197908 - Dinsmore; Christopher J. ;   et al. | 2009-08-06 |
Tyrosine kinase inhibitors Grant 7,550,478 - Dinsmore , et al. June 23, 2 | 2009-06-23 |
Tyrosine Kinase Inhibitors App 20090131423 - Dinsmore; Christopher J. ;   et al. | 2009-05-21 |
Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain App 20070099950 - Lim; Jongwon ;   et al. | 2007-05-03 |
Tyrosine kinase inhibitors App 20060293358 - Dinsmore; Christopher J. ;   et al. | 2006-12-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.